Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/13/2014 | WO2012106385A3 Methods of identifying multiple epitopes in cells |
03/13/2014 | WO2012103355A3 Methods of detecting lung cancer |
03/13/2014 | US20140075585 Tetraspanin CD82 as a Diagnostic and/or Therapeutic Module for Xenograft Recognition and/or Rejection |
03/13/2014 | US20140073714 Posterior Segment Drug Delivery |
03/13/2014 | US20140073701 Methods of preventing, treating and diagnosing disorders of protein aggregation |
03/13/2014 | US20140073686 Compositions for modulating invasion ability of a tumor and methods thereof |
03/13/2014 | US20140073654 Methods for detection of biological substances |
03/13/2014 | US20140073604 Ladder-Frame Polyether Conjugates |
03/13/2014 | US20140073587 Resistance biomarkers for hdac inhibitors |
03/13/2014 | US20140073581 Hybrid Cyclic Libraries and Screens Thereof |
03/13/2014 | US20140073565 Cxcr4 and robo1 expression as markers for autoimmune diabetes |
03/13/2014 | US20140073532 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
03/13/2014 | US20140073527 Methods for diagnosis and prognosis of cancer |
03/13/2014 | US20140073526 Immune function biomarkers |
03/13/2014 | US20140073524 Markers and methods for detecting posttraumatic stress disorder (ptsd) |
03/13/2014 | US20140073523 Use of glycolytic pathways for inhibiting or measuring oncogenic signaling |
03/13/2014 | US20140073522 Pancreatic Cancer Biomarkers and Uses Thereof |
03/13/2014 | US20140073515 Microorganism detection and analysis using carbohydrate and lectin recognition |
03/13/2014 | US20140073062 Specimen solution assay device, specimen solution assay method, and immunochromatographic sensor device |
03/13/2014 | US20140073057 Process and markers for the diagnosis of kidney diseases |
03/13/2014 | US20140073056 Method for identifying gambiered guangdong silk |
03/13/2014 | US20140073043 Systems and methods for multi-analysis |
03/13/2014 | US20140073002 Method for determining differentiation level of pluripotent stem cells |
03/13/2014 | US20140072999 Methods of simulating chemotherapy for a patient |
03/13/2014 | US20140072995 Modulators of ATP-Binding Cassette Transporters |
03/13/2014 | US20140072991 Quantitative standard for mass spectrometry of proteins |
03/13/2014 | US20140072989 Tsh immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues |
03/13/2014 | US20140072988 Determination of vitamin d metabolites in dried blood |
03/13/2014 | US20140072987 Methods of detecing bladder cancer |
03/13/2014 | US20140072986 Amyloid protein oligomer-binding aptamer |
03/13/2014 | US20140072985 Bioassay Method for Antibody Against Thyroid-Stimulating Hormone Receptor, Measurement Kit for the Antibody, and Novel Genetically Modified Cell for Use in the Bioassay Method or the Measurement Kit |
03/13/2014 | US20140072984 Soluble gp130 muteins with improved binding activity |
03/13/2014 | US20140072983 Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies |
03/13/2014 | US20140072982 Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases |
03/13/2014 | US20140072981 Cysteine hydrazide nicotinamide for glycomics and glycoproteomics uses |
03/13/2014 | US20140072980 Isolating cells expressing secreted proteins |
03/13/2014 | US20140072979 Isolating cells expressing secreted proteins |
03/13/2014 | US20140072977 Systems and Methods for Determining a C-Peptide Receptor, C-Peptide Receptor, and Methods of Using Same |
03/13/2014 | US20140072970 Lafora's disease gene |
03/13/2014 | US20140072969 Differential Diagnosis Of Cancer And Other Conditions Based On Expression Of p63 |
03/13/2014 | US20140072963 Electrochemiluminescence immunoassay method |
03/13/2014 | US20140072960 Self diagnostic test |
03/13/2014 | US20140072959 Rapid tests for insurance underwriting |
03/13/2014 | US20140072958 Novel influenza hemagglutinin protein-based vaccines |
03/13/2014 | US20140072651 Methods of treatment using thymus-derived compositions |
03/13/2014 | US20140072592 Method of preparing antigen for acquiring anti-hydrophobic peptide antibody |
03/13/2014 | US20140072580 Novel targets for treatment of hypercholesterolemia |
03/13/2014 | US20140072573 Method of treating rheumatoid arthritis |
03/13/2014 | US20140072571 Osteoporosis associated markers and methods of use |
03/13/2014 | US20140072570 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab |
03/13/2014 | US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
03/13/2014 | US20140072558 Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain |
03/13/2014 | US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
03/13/2014 | US20140071417 Liquid optically clear adhesive lamination process control |
03/13/2014 | US20140070111 Signal processing methods and systems for explosive detection and identification using electromagnetic radiation |
03/13/2014 | US20140069171 Portable environmental audit tool |
03/13/2014 | DE102012018076A1 Klebender Funktionsstreifen zur transkutanen Fluoreszenzmessung sowie zugehörige Herstellungsverfahren und Verwendungen Adhesive strip function for transcutaneous measurement of fluorescence and related manufacturing methods and uses |
03/13/2014 | DE102006022076B4 Transientes Partialflusssamplingsystem mit variabler Ansprechzeit und Verfahren dafür Transient Partialflusssamplingsystem variable response time and method therefor |
03/12/2014 | EP2706360A1 Methods for improving diabetes management |
03/12/2014 | EP2706359A1 Means and methods applying sFlt-1/PlGF or Endoglin/PlGF ratio to rule-out onset of preeclampsia within a certain time period |
03/12/2014 | EP2706358A2 Biomarkers for inhibitors with anti-angiogenic activity |
03/12/2014 | EP2706357A1 Method for identifying subgroups of circulating tumor cells (CTCs) in a CTC population or a sample |
03/12/2014 | EP2706356A1 Methods for identifying HIV neutralizing antibodies |
03/12/2014 | EP2706355A1 System and method for eluting and testing substance from exhaled aerosol sample |
03/12/2014 | EP2706354A1 Multifunctionalized materials |
03/12/2014 | EP2705371A1 Identification of a new molecular factor for early diagnosis of urothelial carcinoma of the bladder |
03/12/2014 | EP2705370A2 Markers for cancer prognosis and therapy and methods of use |
03/12/2014 | EP2705369A1 Method for the detection and early serotyping of the dengue virus |
03/12/2014 | EP2705368A1 Use of ef-1 and the homologues thereof, to detect a p24 retroviral protein or a homologue of same |
03/12/2014 | EP2705367A1 Method for determining the presence or absence of a biomarker |
03/12/2014 | EP2705366A1 Diagnostic device |
03/12/2014 | EP2705365A1 Immunoassay for direct determination of antigen content of products comprising adjuvant-coupled-antigen particles |
03/12/2014 | EP2705364A1 Novel treatment of pain |
03/12/2014 | EP2705363A1 Device and method for non-invasive collection of colorectal mucocellular layer and disease detection |
03/12/2014 | EP2705362A1 Use of ss'-dimethyl-gliotoxin as diagnostic marker of pathologies caused by gliotoxin-producing fungi or their derivatives |
03/12/2014 | EP2705358A1 Device and method for determining the carbon dioxide content of air |
03/12/2014 | EP2705356A2 Conductive patterns and methods for making conductive patterns |
03/12/2014 | EP2705346A1 Method of measuring the viscocity of a fluid and viscosimeter |
03/12/2014 | EP2705180A1 Compositions and methods for antibody and ligand identification |
03/12/2014 | EP2705164A1 A method of diagnosing neoplasms |
03/12/2014 | EP2705154A1 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease |
03/12/2014 | EP2705150A2 A synthetic hepatitis c genome and methods of making and use |
03/12/2014 | EP2705123A1 Quality certification of oxygenated gasoline |
03/12/2014 | EP2704741A1 Methods for handling biological drugs containing living cells |
03/12/2014 | EP2704637A1 Rapid identification of organisms in bodily fluids |
03/12/2014 | CN203479817U Manipulator for automatic blood type detecting instruments |
03/12/2014 | CN203479811U Electronic early-pregnancy rapid detection device |
03/12/2014 | CN203479810U Mouse S100 calcium binding protein B enzyme-linked immunosorbent assay kit |
03/12/2014 | CN203479809U Quantitative Golgi body egg white GP73 determination kit |
03/12/2014 | CN203479808U Connector and applicative test block system thereof |
03/12/2014 | CN203479807U Detection terminal |
03/12/2014 | CN203479806U 96-hole reaction plate |
03/12/2014 | CN203479805U Analysis equipment for detecting analyte in fluid sample |
03/12/2014 | CN203479804U Incubation and centrifugation integrated machine |
03/12/2014 | CN203479803U Closing test device of biology pipe cavity |
03/12/2014 | CN203479802U Safety screening detection card for field operation emergency blood |
03/12/2014 | CN203479801U Device for rapidly measuring water content in crude oil |
03/12/2014 | CN203479800U Novel soil environmental pollution monitor |
03/12/2014 | CN203479799U Measuring device for ground surface source pollutant transport flux |
03/12/2014 | CN203479798U Embedded soil dry and wet indicator |